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Scleractinian corals are the most basal eumetazoan taxon and 
provide the biological and physical framework for coral reefs, 
which are among the most diverse of all ecosystems. Over the 
past three decades and coincident with clim ate change, these 
phototrophic sym biotic organism s have been subject to 
increasingly frequent and severe diseases, which are now geo­
graphically widespread and a major threat to these ecosys­
tem s. A lthough coral im m unity has been the subject o f 
increasing study, the available inform ation remains fragm en­
tary, especially with respect to coral antim icrobial responses. 
In this study, we characterized damicornin from  Pocillopora 
damicornis, the first scleractinian antim icrobial peptide 
(AMP) to be reported. W e found that its precursor has a seg­
m ented organization com prising a signal peptide, an acidic 
proregion, and the C-terminal AMP. The 40-residue AMP is 
cationic, C-term inally amidated, and characterized by the 
presence o f six cysteine m olecules joined by three intram o­
lecular disulfide bridges. Its cysteine array is com m on to  
another AMP and toxins from cnidarians; this suggests a 
com m on ancestor, as has been proposed for AMPs and toxins 
from  arthropods. Damicornin was active in vitro  against 
Gram-positive bacteria and the fungus Fusarium oxysporum. 
Damicornin expression was studied using a com bination of 
im m unohistochem istry, reverse phase HPLC, and quantita­
tive RT-PCR. Our data show that damicornin is constitutively  
transcribed in ectoderm al granular cells, where it is stored, 
and further released in response to nonpathogenic immune 
challenge. Damicornin gene expression was repressed by the 
coral pathogen Vibrio coralliilyticus. This is the first evidence 
o f AMP gene repression in a host- Vibrio interaction.
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Scleractinian corals are the biological, ecological, and 
physical framework of tropical coral reefs, which are among 
the m ost diverse ecosystems on earth. Tropical coral reef 
ecosystems commonly occur adjacent to developing coun­
tries and support m ajor industries including food produc­
tion, tourism , and biotechnology development. However, 
w ith global change, natural disturbances, and anthropogenic 
pressures that are increasing in frequency and severity 
(1 -6 ), coral reefs are endangered. The reasons for this 
alarm ing status are m ultiple and include increasing water 
tem perature, which disrupts symbiosis and leads to coral 
bleaching, and anthropogenic pressures such as overfishing 
tha t lead to ecosystem disequilibrium. Am ong im pacts on 
coral reefs, the incidence of coral disease appears to be 
increasing in frequency and severity (1, 7). This phenom e­
non appears to be aggravated by global warming, and it has 
been suggested tha t high tem peratures influence the ou t­
come of bacterial infections by lowering the resistance of the 
coral to disease and/or increasing pathogen growth, infectiv- 
ity, or virulence (8, 9). Increased virulence has been dem on­
strated  in the bacterium  Vibrio coralliilyticus, where it leads 
to bleaching and tissue lysis in Pocillopora damicornis (10), 
and in Vibrio shiloi, which is the causative agent of bleaching 
in Oculina patagonica  (11). It has been shown tha t an 
increase in tem perature triggers bacteria adhesion and toxin 
and enzyme production  (12, 13).
A lthough the central role of Vibrio species in several coral 
diseases has been widely docum ented, knowledge of the 
effects of Vibrio infection on coral physiology/im m unity is 
rudim entary. One reason is the paucity of inform ation on 
coral immunology, particularly with respect to defenses 
against infectious agents (1, 14). As for all invertebrates, 
coral im m unity is thought to rely on innate m echanisms 
involving pattern  recognition receptors and cellular and 
hum oral responses directed against infectious agents 
(14-22).
There is virtually no information on the antimicrobial 
response of scleractinians. However, several recent studies have 
suggested the involvement of antibacterial agents. Thus, the 
mucus of several species of scleractinians has been shown to
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have antibacterial properties (23-26), and in a recent study on 
the transcriptomic response of P. damicornis to its specific 
pathogenic bacterium V  coralliilyticus (27), we identified an 
mRNA corresponding to a putative antimicrobial peptide 
(AMP).3
We describe here the isolation and characterization of dami­
cornin, the first AMP reported from a scleractinian coral. We 
report the structure of the damicornin precursor, its localiza­
tion in coral tissues, its antimicrobial spectrum against a panel 
of microorganisms including its specific pathogenic bacterium 
V  coralliilyticus, and its expression in corals confronted with 
virulent and avirulent bacteria. Our results show that: (i) dami­
cornin has a cysteine array common to other cnidarian AMPs 
and toxins; (ii) damicornin is expressed and released from coral 
ectodermal cells exposed to a nonpathogenic stimulus; and (iii) 
the gene for expression of damicornin is repressed concomi­
tantly with the invasion of host ectodermal cells by the coral 
pathogen V  coralliilyticus.
EXPERIMENTAL PROCEDURES
Biological Material
The P. damicornis (Linnaeus, 1758) isolate used in this study 
was collected from Lombock, Indonesia (CITES number 
06832/VI/SATS/LN/2001), propagated, and maintained in 
aquaria, as described previously (22). The filamentous fungus 
Fusarium oxysporum and strains of the Gram-positive bacteria 
Micrococcus luteus (A270), Bacillus megaterium  (IBMC), 
Staphylococcus aureus (SG511), Brevibacterium stationis (CIP 
101282), and Microbacterium maritypicum  (CIP 105733T) and 
the Gram-negative bacteria Escherichia coli (SBS 363), Vibrio 
aesturianus (CIP 109791), and Vibrio splendidus (CIP 107715) 
were the same as used in a previous study (28). V  shiloi (CIP 
107136) and V  coralliilyticus strain YB1 (CIP 107925) were 
obtained from the Pasteur Institute (Collection de l’Institut 
Pasteur). V  coralliilyticus was used in biotic stress and infection 
experiments with P. damicornis (29). For routine use V  coral­
liilyticus was cultured in 2216 Marine Broth medium (BD- 
DIFCO 279110) at 30 °C under aerobic conditions with shaking 
(150 rpm). During experimental procedures (see below), it was 
used at the ambient coral maintenance temperature. Experi­
ments to determine which cells (host or symbiont) expressed 
the candidate genes involved the use of three zooxanthellae 
isolates; the origin of and culture conditions for the zooxanthel­
lae have been reported elsewhere (22).
Stress Protocol
The experiments were designed to investigate coral 
responses to bacterial challenge (bacterial stress and bacterial 
infection). Bacterial stress was induced by the addition of V  
coralliilyticus at 25 °C, whereas bacterial infection was induced 
by the addition of V  coralliilyticus under conditions of increas­
ing water tem perature (from 25 to 32.5 °C), which activated
3 The abbreviations used are: AMP, antim icrobial peptide; MIC, minimal inhib­
itory concentration; Dn, day n; RACE, rapid amplification of cDNA ends; 
q-RT-PCR, quan tita tive RT-PCR; Tricine, N-[2-hydroxy-1,1-bis(hydroxy- 
methyl)ethyl]glycine; MBC, minimal bactericidal concentration; PB, poor 
broth.
bacterial virulence. W e recently reported that the bacterium 
becomes virulent at a tem perature of 28 °C (27).
Bacterial stress and infection treatm ents and appropriate 
controls were established in four separate 120-liter tanks as 
follows: (i) V  coralliilyticus added at a constant temperature of 
25 °C (Cb); (ii) V  coralliilyticus added with a gradual tem pera­
ture increase from 25 to 32.5 °C (Tb); (iii) a constant tem pera­
ture of 25 °C without bacteria added (C); and (iv) a gradual 
tem perature increase from 25 to 32.5 °C in the absence of added 
bacteria (T). Nubbins of P. damicornis (fixed piece of coral of 
— 10 g) were randomly placed in each experimental tank (n = 
40/tank) and acclimatized at 25 °C for 2 weeks. Bacteria were 
added to the Cb and Tb treatm ent tanks every 3 days by balnea­
tion (12). Briefly, this involved washing the bacteria twice in 
filtered sea water (0.22 jum) and adding the washed cells to the 
tank to achieve a concentration of IO3 cells/ml of tank water. 
W ater circulation ensured the homogenous distribution of bac­
teria in the tank. The cultures of V  coralliilyticus were grown at 
25 °C for the Cb treatm ent and at the tem perature correspond­
ing to that of the tank for Tb. For the Tb treatm ent and the T 
control, the temperature was increased by 1.5 °C every 3 days, 
beginning on day 3 (D3), until it reached 32.5 °C. ThreeP. dam i­
cornis nubbins were randomly sampled from each tank every 3 
days (DO, D3, D9, D12, D15, and D18).
The tank temperature was controlled using an aquarium heater 
(600 W, Schego) connected to an electronic thermostat (Hobby 
Bio therm Professional). Illumination was supplied at an irradiance 
of 250 jumol photon/m 2/s (measured using a quantum meter; 
QMSW-SS, Apogee Instruments Inc.) using metal halide lamps 
(Iwasaki 6500 Kelvin, 400 W) set to a 12-h light:12-h dark photo­
period. All other seawater parameters were held constant over 
time in the tanks. A water pump (IDRA, 1300 liters/h) continu­
ously recycled the tank seawater at a rate of 10.8 tank volumes/h, 
passing it through a biological filter and an Aquavie protein skim­
mer (EPS 600). A proportion of the tank water (2%) was replaced 
each day with natural filtered Mediterranean seawater heated to 
25 °C. T o avoid the growth of bacterial blooms, the water was con­
tinuously treated using a UVC filter (JBF, AquaCristal Series II, 5 
W). At each time of addition of V  coralliilyticus, all of the equip­
ment known to remove or kill bacteria (the protein skimmer and 
the UVC filter) was inactivated for 4 h to allow the bacteria to 
adhere to the coral tissues.
RNA Extraction and Complete Open Reading Frame 
Characterization o f the Putative AMP
RACE-PCR experiments were performed to characterize the 
complete ORF of the putative AMP. Tissue extraction, total 
RNA extraction, poly(A) + purification, and RACE-PCR were 
conducted using nonchallenged P. damicornis nubbin, as 
described previously (22).
Quantitative RT-PCR Analyses
Quantitative RT-PCR (q-RT-PCR) was used to analyze the 
expression profile of the putative AMP. Total RNA was 
extracted, and 2.5 pg  was reverse transcribed using oligo(dT) 
primers and the Superscript II enzyme (Invitrogen). The result­
ing cDNA products were purified using a Nucleotrap gel 
extraction trial kit (Clontech), and q-RT-PCR was performed
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TABLE i
Primers used  for q-RT-PCR
Gene name Forward primer (5' -h>3') Reverse primer (5' —> 3')
Preprodamicornin
Major basic nuclear protein
60 S ribosomal protein L22
60 S ribosomal protein L40A
60 S acidic ribosomal phosphoprotein PO
AGTCCCAGAAAAGCGG 
GGTACAGCAAACTGCG 
TGATGTGTCCATTGATCGTC 
C GACTGAGAGGAGGAGC 
GCTACTGTTGGGTAGCC
GTGGGTAACATCGCGT 
TTGGAAACGTCCGACC 
CATAAGTAGTTTGTGCAGAGG 
CTCATTTGGACATTCCCGT 
CTCTCCATTCTCGTATGGT
using 2.5 /xi of purified cDNA (diluted 1:50 in water) in a total 
volume of 10 /xi containing IX LightCycler® 480 SYBR Green I 
Master Mix (Roche Applied Science) and 70 nM of each primer. 
The primers, which were designed using the Light Cycler Probe 
Design Software, version 1.0 (Roche Applied Science), are 
shown in Table 1. Amplification was performed using a Light­
Cycler 480 system (Roche Applied Science) and the following 
reaction conditions: activation of the Thermo-Start® DNA 
polymerase at 95 °C for 15 min, followed by 45 cycles of 
dénaturation  at 95 °C for 30 s and annealing/extension at 
60 °C for 1 min. M elting curve profiles were assayed to 
ensure tha t a single product was amplified. Each run 
included a positive cDNA control tha t was sampled at the 
beginning of the experim ent (DO) and also from  each am pli­
fication plate; this positive control was also used as the cali­
brato r sample, and blank controls (water) were included for 
each prim er pair. The PCR products were resolved by elec­
trophoresis, the bands were isolated directly from  agarose 
gels, and DNA was extracted using the gel extraction PCR 
purification system V (Promega). The resulting q-RT-PCR 
products were single-pass sequenced as described above.
For each reaction, the crossing point (Cp) was determined 
using the second derivative max method applied by the Light­
Cycler Software, version 3.3 (Roche Applied Science). The PCR 
efficiency (£) of each primer pair was calculated by determining 
the slope of standard curves obtained from serial dilution anal­
ysis of the cDNAs pooled from all experimental samples, as 
described previously (30). The individual q-RT-PCR efficiencies 
for the target or reference genes were calculated using the formula: 
£  = io (~1/sl°Pe). The transcription level of the putative AMP was 
normalized using the mean geometric transcription rate of three 
reference genes encoding ribosomal proteins, obtained from P. 
damicornis: 60 S ribosomal protein L22, 60 S ribosomal protein 
L40A, and 60 S acidic ribosomal phosphoprotein P0 (GenBank™ 
accession numbers H O I 12261, HOI 12283, and HOI 12666, 
respectively). The stable expression status of these three genes 
under nonstress, thermal stress, bacterial stress, and bacterial 
infection conditions was recently demonstrated (27). The normal­
ized relative quantities (NRQ) were calculated as described previ­
ously (31), using the equation,
£-AQw„,
where £ target is the amplification efficiency of the gene of inter­
est; £ ref is the amplification efficiency of the reference gene; 
ACp,ref = Cp,ref(calibrator) -  Cp,ref(sample); and ACp,target = 
Cp.target(calibrator) -  Cp,target(sample).
Identification o f the Organism Expressing the Putative AMP
To determine which organism (host or symbiont) expressed 
the putative AMP gene, cross-PCR experiments were per­
formed on DNA and RNA extracted from the holobiont (host 
plus symbiont) and from pure cultured zooxanthellae, as 
described previously (22). Briefly, PCR amplifications were per­
formed with oligonucleotides amplifying the AMP, housekeep­
ing genes, the gene encoding the small ribosomal subunit RNA 
of Symbiodinium  spp. (32), and the cDNA encoding the major 
basic nuclear protein (GenBank™  accession number 
H0112459) of Symbiodinium  spp. (Table 1).
Production o f Synthetic Peptide and Antibodies
The putative peptide (ACADLRGKTFCRLFKSYCDKKGIR- 
GRLMRDKCSYSCGCR-NH2) was chemically synthesized (5 
mg; Genepep, Saint-Clément de Rivière, France) in a C-termi- 
nally amidated form, and the folding of the three disulfide 
bonds was performed. The HPFC purity of the peptide was 96%.
The synthetic peptide was used to assess the antimicrobial 
activity of the putative AMP and to immunize New Zealand 
rabbits, as described previously (33). Serum from nonim m u­
nized and immunized rabbits was collected 70 days after initial 
injection and tested for the presence of specific Igs (antibody or 
IgG) using EFISA (34) with uncoupled synthetic peptide 
adsorbed onto M axiSorp™  plates (Nunc). The IgG fraction 
was purified using affinity chromatography (35), and antibody 
specificity was tested by W estern blot. Briefly, coral proteins 
and the synthetic peptide were subjected to Tris-Tricine 
(16.5%) gel electrophoresis and electroblotted onto a PVDF 
membrane. To verify the specificity, the blots were probed with 
preimmune and purified immune sera at a dilution of 1:1000. 
The remainder of the procedure was performed as described 
previously (36).
Immunolocalization Experiments
Tissues of P. damicornis from unstressed coral colonies or 
from coral colonies stressed with nonvirulent bacteria were 
processed following a procedure described elsewhere (37). 
Thin sections (7 /xm) of tissues embedded in Paraplast were cut, 
m ounted on silane-coated glass slides, and stored at 4 °C in a 
dry atmosphere. The paraffin was removed from the sections, 
which were incubated for 1 h at room  tem perature in a saturat­
ing medium containing 2% BSA, 0.2% teleostean gelatin, 0.05% 
Tween 20, and 0.5% donkey serum in 0.05 mol/liter PBS at pH 
7.4. The sections were then incubated overnight at 4 °C in a 
moist chamber with the purified antibodies raised against syn­
thetic damicornin (85 /xg/ml in saturating medium) or with the 
depleted purified antibodies raised against synthetic dami­
cornin (depletion was performed by preincubating the purified
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antibodies for 1 h at room  tem perature with the synthetic dami­
cornin). Excess antibodies were removed by repeated rinsing, 
and the sections were then incubated for 1 h at room tem pera­
ture with biotinylated anti-rabbit antibodies (secondary anti­
bodies; Amersham Biosciences RPN1004) diluted 1:250 in the 
saturating medium. After incubation, the sections were rinsed 
with PBS (pH 7.4) and stained for 15 min with streptavidin 
AlexaFluor 568 (S11226; Molecular Probes) diluted 1:50 in PBS 
and DAPI (D9542; Sigma; 2 jug/ml). The sections were 
m ounted in Pro-Long antifade medium (P7481; Molecular 
Probes) and observed using a confocal laser-scanning micro­
scope (TCSSP5; Leica).
Analysis o f P. damicornis Tissues by Reverse Phase HPLC and 
MALDI-TOF MS
To detect the native antimicrobial peptide in coral tissues, 
nine coral nubbins (sampled from the Cb and C tanks) were 
harvested, and the tissue was extracted using a water pick (800 
ml of 0.2-jum filtered seawater refrigerated at 4°C). The 
extracts were centrifuged at 3000 X g  for 10 min at 4 °C. The 
extract supernatant was discarded, and the pellet was resus­
pended in 10 volumes of 2 m  acetic acid and homogenized (15 
strokes) using a Dounce homogenizer (100 jum). The homoge- 
nate was placed in a 4°C water bath and sonicated (Vibra- 
cell™  75185, medium power, three pulses of 30 s), then stirred 
over night at 4 °C, and finally centrifuged at 10,000 X g  for 20 
min at 4 °C to remove cellular fragments. The supernatant was 
immediately collected and prefractionated using a Sep-Pak C18 
Vac cartridge (Sep-Pac Vac 12cc; W aters Corporation). Briefly, 
the Sep-Pak column was washed using acidified water with TFA 
(0.05%), and three successive elutions were performed with 10, 
60, and 80% acetonitrile in acidified water. The fractions 
obtained were lyophilized and reconstituted with 1 ml of acid­
ified water (0.05% TFA). The reconstituted extracts were cen­
trifuged for 20 min at maximum speed and 4 °C and tested for 
antimicrobial activity as described below.
All of the HPLC purification steps were performed using a 
W aters Breeze system (Waters 1525, binary HPLC pump) 
equipped with a UV detector (Waters 2487, dual À absorbance 
detector). The column effluent was monitored by UV absorp­
tion at 224 and 280 nm. Fractions were hand-collected and 
tested for antimicrobial activity.
Aliquots (150 jul) of Sep-Pak fractions with antimicrobial 
activity were subjected to reverse phase HPLC using a Symme­
try C18 column (250 mm X 4.6 mm; Waters). Elution was per­
formed with a linear gradient of 15-85% acetonitrile in acidi­
fied water over 70 min at a flow rate of 1 ml/min. Fractions 
corresponding to absorbance peaks were collected in polypro­
pylene tubes, freeze dried, reconstituted in 0.1 ml of acidified 
ultrapure water, and tested for antimicrobial activity as 
described below. The active fraction was again subjected to 
reverse phase HPLC using a Symmetry C8 column (150 mm X 
2.1 mm; Waters). Elution was performed with a linear gradient 
of 45-55% acetonitrile in acidified water over 60 min at a flow 
rate of 0.3 ml/min. Fractions corresponding to absorbance 
peaks were collected in polypropylene tubes, freeze dried, 
reconstituted in 0.03 ml of acidified ultrapure water, and tested 
for antimicrobial activity or submitted to MS analysis. The
dried active fraction or 20 jug of synthetic peptide was resus­
pended in 10 jul of pure water (ultra liquid chromatography/ 
mass spectrometry solvent; Biosolve).
MALDI-TOF mass measurements were carried out using an 
Ultraflex™  TOF/TOF mass spectrometer (Bruker Daltonics 
GmbH, Bremen, Germany) at a maximum accelerating poten­
tial of 25 kV in positive mode and in either linear or reflectron 
mode. Each sample (1 jul) was co-crystallized on stainless steel 
MALDI targets with 1 jul of 4-hydroxy cinnamic acid (10 mg/ml 
of acetonitrile in aqueous 0.1% TFA, 7:3 v/v) using the dried 
droplet method of matrix crystallization. External calibration of 
the MALDI mass spectra was carried out using singly charged 
monoisotopic peaks (Pepmix calibration standard; Bruker Dal­
tonics, Wissembourg, France).
The same molecules were also treated by tryptic digestion 
prior to MALDI-TOF mass spectrometry. The tryptic digestion 
was conducted directly on stainless steel MALDI targets. A 1-jul 
sample was first reduced in 1 julofa2X  DTT solution (20 m M  in 
NH4H C 0 0 3, 50 m M ) for 30 min at 55 °C in a moist chamber. 
Secondly, alkylation was performed in the dark at room  tem ­
perature in a moist chamber by adding 1 jul of a 2X iodoacet- 
amide solution (110 m M , in NH4H C 0 0 3, 50 m M ) and incubat­
ing for 30 min. The protein samples were then digested by the 
addition of 2 jul of a trypsin (sequence grade; Promega, Char­
bonnière, France) solution (40 jug/ml, reconstituted just prior 
to use in 50 m M  NH4H C 0 0 3) and incubation overnight at 37 °C 
in a moist chamber. For MALDI-MS analysis, 1 jul of 4-hy- 
droxycinnamic acid was spotted onto the digest and dried.
Disulfide Bond Assignment o f Damicornin
The experiments to establish the positions of the disulfide 
bonds in the putative AMP were performed using a MALDI 
LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scien­
tific, Bremen, Germany) with automatic gain control turned on. 
The signal was optimized by adjusting the laser energy to 6 - 8  
juJ. The default target values were used in all experiments. Both 
MS and MS/MS experiments were acquired in centroid mode. 
A 2-Da mass window was used for MS/MS precursor selection. 
Qualitative data were obtained using Xcalibur™  software. The 
Orbitrap analyzer was calibrated with the aid of a calibrated 
peptide mixture (MSCAL4; Sigma-Aldrich) for optimization in 
the mass range 200-4000.
Native peptide was digested with chymotrypsin without prior 
reduction and alkylation. A sample (2 jul) was digested with 2 jul of 
a chymotrypsin (sequence grade; Promega, Charbonnière, France) 
solution (0.04 jug/jul in 50 m M  NH4H C 0 0 3). Digestion was per­
formed overnight at 30 °C and spotted onto a stainless steel 
MALDI target, as described previously. Controls for chymotrypsin 
digestion were conducted in water or with the synthetic peptide.
Antimicrobial Assays
Antibacterial Activity o f HPLC Fractions—Following each 
HPLC purification step, the antibacterial activity was assessed 
using a liquid growth inhibition assay (38). Briefly, 10-jul ali­
quots of the resuspended fractions were incubated in microtiter 
plates with 100 jul of Luria-Bertani broth (LB) suspensions of 
each ofM. luteus (starting A 600, 0.001) and£. coli (starting A 600, 
0.001). Antibacterial activity was assayed by measurement of
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FIGURE 1. Damicornin, aurelin, and anemonia toxins share the same cysteine array. The putative cleavage site is indicated by th e  double-ended arrow. 
Conserved am ino acids are highlighted in gray. The conserved cysteine array is highlighted in bold gray and outlined in black. The anem onia toxins ShK, BgK, 
and HmK are produced by th e  anem ones S. helianthus, B. granulifera, and H. magnifica, respectively. The essential dyad for toxins blocking voltage-gated  K+ 
channels is underlined. Anem onia toxin disulfide pairing (Cl -C6, C2-C4, and C3-C5) is indicated under toxin sequences.
bacterial growth (A600) following incubation for 12 h at 30 °C 
for M. luteus and 37 °C for E. coli.
Determination o f M inim al Bactericidal Concentration 
(MBC)—Antibacterial activity was assayed against several bac­
teria. MBCs were determined as described previously (39). A 
solution of 0.01% acetic acid and 0.2% BSA was used to dissolve 
and prepare a series of 2-fold dilutions of the synthetic peptide. 
Aliquots (10 [A) from each dilution were incubated in sterile 
96-well polypropylene microtiter plates with 100 /xi of a sus­
pension of test bacteria (starting A600, 0.001) in poor broth (PB; 
1% Bacto tryptone) or PB supplemented with NaCl (PB-NaCl; 
15 g/liter) for marine bacteria or in marine broth 2216 for 
Vibrio species. Bacterial growth was assessed after incubation 
with agitation at 30 °C for 18 h or at 23 °C and 30 °C for V. shiloi 
and V  coralliilyticus. The MBC was determined by plating the 
contents of the first three wells having no visible bacterial 
growth onto LB agar plates and incubating at 30 °C for 18 h. The 
lowest concentration of synthetic peptide that prevented col­
ony formation was recorded as the MBC.
Determination o f M inimal Inhibitory Concentration (MIC)— 
MICs were determined using a liquid growth inhibition assay 
based on a procedure described previously (40). Marine broth 
2216 was used for Vibrio sp., PB-NaCl was used for other 
marine bacteria, and PB was used for the remaining microor­
ganisms. Briefly, 10 /xi from each dilution of the synthetic pep­
tide was incubated in a microtiter plate with a 100-/xi suspen­
sion of each of the bacteria at a starting A 600 of 0.001. The MIC 
was recorded as the lowest dilution inhibiting bacterial growth 
(measured at A 600) after incubation for 18 h at 30 °C or 30 °C 
and 23 °C for V  shiloi and V  coralliilyticus.
Bactericidal Assay—Synthetic peptide (10 /xi) at a concentra­
tion 10-fold higher than the MIC (12.5 /x m ) was mixed with 90 
/xi of an exponential phase PB culture of M. luteus (starting 
A 6oq, 0.01). Following incubation at 30 °C for 0,1, 3,10, and 30 
min and 2,6, and 24 h, aliquots (10 /xi) were plated onto LB agar, 
and the number of colony forming units was counted after 
overnight incubation at 30 °C. Controls consisted of bacterial 
culture incubated with 10 /xi of sterile water.
Antifungal Assay—Antifungal activity was monitored against 
F. oxysporum using a liquid growth inhibition assay as 
described previously (41).
Hemolysis Assay—A solution of 0.01% acetic acid and 0.2% 
BSA was used to dissolve synthetic peptide (400 / x m ) and pre­
pare a series of 2-fold dilutions. An aliquot (20 /xi) from each 
dilution was added to 180 /xi of a PBS (pH 7.4) solution contain­
ing sheep erythrocytes (5%, v/v). As a positive control for 
hemolysis, 20 /xi of 10% Triton X-100 in PBS replaced the pep­
tide solution. The negative control consisted of 20 /xi of the 
0.01% acetic acid and 0.2% BSA solution. Following incubation 
for 2 h at 37 °C, the test solutions and controls were centrifuged 
for 3 min at 10,000 X g. The absorbance of the supernatants was 
measured at 570 nm (AD340; Beckman Coulter), and the per­
centage hemolysis was calculated as % hemolysis = (A570 sam­
ple — A 570 negative control)/(A570 positive control — A 570 neg­
ative control) X 100.
Statistical Analysis
Variations in gene expression were analyzed separately all along 
the nonvirulent (Cb set) and virulent (Tb set) treatments using 
Grubbs’ test (42,43), which detects kinetic points that deviate sig­
nificantly from the others (Le. outliers). Statistical tests were per­
formed using JMP software (SAS Institute, Inc.), and differences 
were considered statistically significant at the 5% level.
RESULTS
Characterization o f the Damicornin Precursor—In a study of 
the transcriptomic response of P. damicornis to bacterial stress 
or infection (27), we identified an expressed sequence tag with 
amino acid sequence similarities to the prepro-aurelin gene 
(GenBank™  accession number DQ837210), which encodes 
the precursor of an AMP in the jellyfish Aurelia aurita 
(BLASTX, E  value = 1.4; amino acid alignment shown in Fig. 1). 
The complete cDNA, which was obtained by RACE-PCR (Fig. 
2), consists of 751 nucleotides and contains an ORF encoding a 
107-amino acid precursor sequence. This sequence has the 
canonical prepropeptide organization of many AMP precur­
sors. It consists of a 22-amino acid N-terminal sequence (Met-1 
to Ala-22), which is highly hydrophobic and corresponds to a 
putative signal peptide (prepeptide), as predicted by the Sig- 
nal3.0 software. This is followed by a highly acidic 45-amino 
acid sequence (Ala-23 to Arg-67) with a calculated pi of 3.56. 
Anionic amino acids (Asp and Glu) were found at 16 positions 
in this proregion, which ends with a dibasic motif (Arg-66 to 
Arg-67) consistent with the putative cleavage site. The C-ter- 
minal sequence (Ala-68 to Gly-107) corresponds to the putative 
AMP and has an identical cysteine array and 37.3% amino acid 
sequence identity with aurelin from A. aurita  (Fig. 1). The puta­
tive AMP of P. damicornis has several features of eukaryotic 
AMPs: (i) a high content of basic amino acids (pi 9.64); (ii) six 
Cys residues apparently involved in disulfide bond formation; 
and (iii) a C-terminal Gly residue that could be a signal of ami­
dation (44). This putative AMP was termed damicornin, and 
the complete cDNA sequence was submitted to GenBank™  
(accession number HQ825099).
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FIGURE 2. cDNA and deduced amino acid sequences of preprodami- 
cornin. The ORF sequence  is show n in capital letters. The expressed sequence  
tag  obtained  from th e  subtractive subtraction hybridization library is high­
lighted in gray. The deduced  am ino acid sequence  of th e  ORF is indicated 
above th e  nucleotide sequence. The asterisk indicates th e  stop  codon. The 
arrow  identifies th e  cleavage site of th e  signal peptide. The dibasic cleavage 
site betw een th e  acidic N-terminal proregion and th e  cationic C-terminal 
region is outlined in black. The dam icornin active pep tide is underlined in 
black. The cysteine residues and glycine am idation signal are show n in bold.
Isolation, Biochemical Characterization, and Disulfide 
Assignment o f Native Damicornin—To demonstrate the pres­
ence of damicornin in coral tissues, we prepared an acidic 
extract of corals that had been maintained at 25 °C and exposed 
to V. coralliilyticus for 9 days. Unchallenged controls were also 
prepared. Following an initial prefractionation step, which was 
applied to each acidic extract using Sep-Pak cartridges (see 
“Experimental Procedures”), only the 60% acetonitrile fraction 
of the extract of V. coralliilyticus-exposed corals had antibac­
terial activity. This fraction was further separated using reverse 
phase HPLC. All of the fractions were tested for activity against 
M. luteus A270 (a sensitive Gram-positive strain) and E. coli 
SBS 363 (a sensitive Gram-negative strain). Only one fraction 
(Fig. 3A) was active, against M. luteus. This was eluted in 51% 
acetonitrile and subjected to a further reverse phase HPLC sep­
aration step. Only one fraction was active, against M. luteus 
(Fig. 3B). The MALDI mass spectrum of the active fraction 
(acquired in positive linear mode) showed a major ion at m lz = 
4492.740 (Fig. 4A), which corresponds to the calculated average 
mass of damicornin (4492.35 Da) starting with an alanine resi­
due at position 68 of the damicornin preprosequence, ending 
with C-terminal amidated arginine residue (resulting from Gly- 
107 removal) and displaying oxidized cysteines. A peptide cor­
responding to this mature sequence was obtained by chemical 
synthesis and had a mass identical to that of the active peptide, 
as determined by MALDI-TOF MS (Fig. 4A). The active pep­
tide from P. damicornis and the synthetic damicornin were sub­
jected to tryptic digestion and mass spectrometry analysis. The 
molecular mass fingerprints of both digests were similar. The 
molecular mass fingerprints of both trypsic digests presented a 
similar pattern with seven common peptides identified and corre­
sponding to damicornin (Fig. AB). Altogether, these data show that 
damicornin is expressed in coral tissues and is processed as it was 
hypothesized above. Damicornin contains six cysteine residues
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FIGURE 3. Purification of damicornin from acidic extracts obtained from 
challenged coral tissue. A, following prepurlflcatlon by solid phase extrac­
tion, th e  material e lu ted  from th e  fraction with 60% acetonitrile was loaded 
on to  a C18 colum n. In this HPLC step, elution was perform ed with a linear 
gradient of 15 to  85% acetonitrile over 60 min at a flow rate of 1 ml/min. 
A bsorbance peaks w ere m onitored a t 224 nm. The fraction containing the  
antim icrobial activity is indicated by an arrow. B, chrom atogram  from th e  last 
reverse phase purification of dam icornin on a C8 column; th e  arrow  indicates 
th e  fraction containing th e  purified antim icrobial pep tide of interest.
involved in three intramolecular disulfide bonds and is C-termi- 
nally amidated by removal of the C-terminal glycine.
For the determination of disulfide pairing between the six 
cysteine residues of the damicornin, we first digest native pep­
tide with chymotrypsin, omitting the reduction alkylation steps 
to preserve disulfide bridges. For three disulfide bridges, 15 
possible disulfide bond pairing schemes can be predicted. The 
peptidic fragments resulting from the chymotrypsin digest 
were analyzed by MALDI LTQ Orbitrap mass spectrometer. As 
illustrated in supplemental Fig. SL4, the presence of pseudo- 
molecular ions [M + H ]+ at m /z  1437.64,1667.83, and 1766.71 
were consistent with a possible pairing scheme C1± with C32, 
C18 with C36 or C38, and C2 with C36 or C38. To confirm this 
possible pairing scheme, ion fragmentation reactions were con­
ducted by collision-induced dissociation. Fragmentation of ion 
at m /z  1437.64 (supplemental Fig. STB) confirmed the C11-C32 
pairing. Because the C-terminal fragment SC36GC38R-NH2 
obtained by chymotrypsin digestion includes two cysteines, the 
assignment of the two other disulfide bridges was partial, and 
results did not provide an unambiguous distinction between 
bonding to C36 or to C38. Nevertheless, fragmentation of ions at 
m /z  1766.71 and m /z  1667.84 (supplemental Fig. SI, C and D) 
confirmed the pairing scheme C2-(C36 or C38) and C18-(C36 or
10 20 30 40 50
Minutes
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FIGURE 4. Identification of damicornin by mass spectrometry analysis.
A, superim posed linear m ode MALDI m ass spectra o f  purified dam icornin and 
synthetic pep tide , show ing a m ajor peak at 4492.740 Da. B, analysis o f tryptic 
d igests o f purified p e p tid e a n d  synthetic p ep tid e  by MALDI-TOF MS. The p ep ­
tides identified by MS analysis are  outlined  and  reported  to  th e  dam icornin 
sequence. The theoretical m asses are  show n, and th e  corresponding m /z  
ratios are  su rrounded on  each MS spectrum .
C38). The same cysteine connections were also obtained for the 
synthetic damicornin (data not shown).
In addition, Fig. 1 gives the alignment of damicornin with the 
anemonia potassium channel toxins ShK, BgK, and HmK (iden­
tified in the anemones Stichodactyla helianthus, Bunodosoma 
granulifera, and Heteractis magnifica, respectively (45-47)). 
This alignment shows that all of these molecules share the same 
cysteine array. Note that the data obtained on damicornin cys­
teine connectivity (supplemental Fig. SI) were consistent with 
those obtained for these anemonia toxins (given in Fig. 1).
Antimicrobial Activity o f Damicornin—Because only small 
amounts of purified native damicornin were obtained, the syn­
thetic peptide was used in antimicrobial assays. In liquid growth 
inhibition assays, damicornin showed potent antifungal activity 
against the filamentous fungus F. oxysporum, with an MIC of 1.25 
/ x m  (Table 2). It was also active against Gram-positive bacteria.
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TABLE 2
Minimal inhibitory concentrat ion  and minimal bactericidal concentra­
tion o f  damicornisn
MBC were determined by testing different concentrations of synthetic peptide in 
liquid growth inhibition assays against different bacterial strains according to the 
Hancock method. ND, not done.
Microorganisms MIC MBC
p M p M
Gram-positive bacteria
B. megaterium (souchier IBMC) 20 >20
S. aureus (SG511) 5 >20
Aí. luteus (A270) 1.25 2.5
B. stationis (CIP 101282)a 10 10
Aí. maritypicum (CIP 105733T)a 20 >20
Gram-negative bacteria
E. coli (SBS 363) 10 20
V. aesturianus (CIP 109791)a >20 >20
V shiloi (CIP 107136)a’b >20 >20
V coralliilyticus strainYBl (CIP 107925)a,b >20 >20
V. splendidus (CIP 107715)a >20 >20
Fungi
F. oxysporum 1.25 ND
a Marine bacteria.
b For these strains, the MIC and MBC were tested at either 23 or 30 °C. The re­
sults were the same at both temperatures.
TABLE 3
Bacteriolytic effect  o f  damicornin  on  M. luteus
Time of incubation Control AMP
l ( f  CFU-mr1 l ( f  CFU-mr1
0 min 2.40 2.46
1 min 2.94 2.86
3 min 2.96 2.89
10 min 3.68 2.58
30 min 3.81 1.95
2 h 3.86 1.30
6 h 9.60 0.00
24 h 22.40 0.00
The MBC was 2.5 /xm against M . luteus and varied from 5 to 
20 / x m  against the other Gram-positive bacteria. However, no 
activity was observed against most of the Gram-negative bacte­
ria, even at the highest concentration tested (20 / x m ); the excep­
tion was E. coli SBS 363 (MBC = 20 / x m ).
The bactericidal effect of synthetic damicornin against 
Gram-positive bacteria was tested in kinetic experiments. 
Damicornin was incubated with M. luteus at a concentration 
10-fold higher than the MIC, and the inhibition of bacterial 
growth was monitored over time. After 6 h, M. luteus had lost 
the ability to grow on LB agar (Table 3). We therefore con­
cluded that damicornin was bactericidal against M. luteus.
We found that sheep red blood cells were not affected by 
exposure to damicornin at concentrations as high as 80 / x m  for 
24 h (data not shown). This indicates that damicornin has no 
hemolytic activity.
Localization o f Damicornin in Holobiont Tissues— The 
sequence similarities between damicornin and the jellyfish 
aurelin suggest that damicornin is expressed by coral cells and 
not by the symbiont. To verify that the preprodamicornin 
encoding gene is expressed by the cnidarians host, we devel­
oped cross-PCR experiments using DNA and cDNA extracted 
from the holobiont (host plus symbiont) and from pure cultures 
of Symbiodinium  spp. clades B, C, and D (Fig. 5). The PCRs 
were performed using primers amplifying (i) the damicornin 
gene, (ii) housekeeping genes, (iii) small ribosomal subunit 
RNA genes from Symbiodinium  spp. (32), and (iv) the major
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HgDNA ZgDNA HcDNA ZcDNA H20
Zx SSz (1600 bp)
Major basic nuclear protein (240 bp)
Preprodamicornin ( 182 bp)
60S ribosomal protein L22 (155 bp)
60S ribosomal protein L40A (159 bp)
60S acidic ribosomal phosphoprotein P0 (165 bp)
FIGURE 5. The preprodamicornin gene is expressed by the coral host. The
presence of preprodam icornin, th e  reference g en e  for q-RT-PCR, th e  small 
ribosomal subunit RNA of th e  zooxanthellae (Zx ssRNA), and th e  gen e  corre­
sponding to  th e  major basic zooxanthellae nuclear protein w ere investigated 
by PCR (using specific primers) on DNA and cDNA extracted from holobionts 
(corals plus zooxanthellae) or from pure cultures o fc lade  B, C, and D zooxan­
thellae. HgDNA, holobiont genom ic DNA; ZgDNA, zooxanthellae genom ic DNA; 
Hcdna/ holobiont cDNA; ZcDNA, zooxanthellae cDNA.
basic nuclear protein gene of Symbiodinium  spp. The dami- 
cornin-specific primers gave amplicons for DNA and cDNA 
from holobionts only (Fig. 5). In contrast, the small ribosomal 
subunit RNA and major basic nuclear protein primers ampli­
fied DNA and cDNA from both holobiont and symbiont cul­
tures. As with the damicornin gene, the three q-RT-PCR refer­
ence genes (encoding the ribosomal proteins L22, L40A, and 
P0) were only expressed in samples containing coral cells. This 
indicates that the damicornin and reference genes are 
expressed by coral cells.
Damicornin expression was monitored in coral tissue sec­
tions using antibodies raised against the synthetic peptide. The 
antibody specificity was tested using W estern blotting (supple­
mental Fig. S2). This experiment, performed on unstressed 
coral, showed there was a molecular mass difference between 
the synthetic damicornin and the band found in coral extracts 
(—10 kDa). This suggests that damicornin may be stored as a 
precursor in coral tissues. The expected molecular mass of the 
prodamicornin was 9.3 kDa. Because antibacterial activity was 
detected by reverse phase HPLC fractionation of extracts of 
coral tissue stressed by bacterial exposure, the localization of 
damicornin was investigated in unstressed corals as well as 
those subjected to bacterial stress. This enabled visual assess­
m ent of the localization and concentration of damicornin in 
corals of different immune status. To impose bacterial stress, 
the corals were exposed to nonvirulent V  coralliilyticus for 9 
days prior to tissues fixation. Similar results were obtained 
under either condition. Corals are diploblastic animals com­
posed of two tissue types: oral and aboral (Fig. 6, panel A Í). 
Tissue sections stained with D API are shown in Fig. 6 (panel 
A2). The reduced background obtained with this blue staining 
of the nucleus highlights the two cellular layers constituting 
each tissue type. The four different layers/epithelia can be easily 
distinguished. Briefly, the oral layer is composed of oral ecto­
derm (exposed to the seawater) and oral endoderm (exposed to 
the coelenteron or gastric cavity). The aboral layer is composed 
of aboral endoderm (exposed to the coelenteron) and the aboral 
ectoderm (in contact with the skeleton), which is also referred 
to as the skeletogenic tissue. The ectoderm and endoderm (oral 
and aboral) are separated by an acellular layer, the mesoglea. 
Damicornin-specific antibodies specifically labeled cells in the 
oral ectoderm (Fig. 6, panel Cl). At higher magnification, the
FIGURE 6. Immunolabeling of damicornin in ectodermal granular cells in 
oral tissue. A 7 and A2, bright field transm itted  light im age {AÍ)  and an im age 
of th e  DAPI-stained nucleus (A2) show ing th e  four tissue layers and th e  coel­
en teron  {i.e. th e  gastric cavity) and their position in relation to  th e  seaw ater 
(SI/I/) environm ent and th e  coral skeleton {SK). BÍ and B2, control experim ents 
perform ed using anti-dam icornin antibodies th a t w ere p readsorbed with th e  
synthetic pep tide used for imm unization. C l, C2, and C3, th e  labeled dam i­
cornin appears bright orange. 62 and C2 are m agnifications of BÍ and C l, 
respectively. Both show  granular ectoderm al cells (GC) with labeling (C2) and 
w ithout labeling in th e  control experim ent {B2). C3 show s ano ther area of th e  
oral ectoderm  {OEc) with th ree  labeled granular cells. Zx, zooxanthellae; OEn, 
oral endoderm ; Me, m esoglea.
staining was associated with cells containing intracellular gran­
ules (Fig. 6, panels C2 and C3). Controls treated with the 
depleted antibody (i.e. antibodies preincubated with synthetic 
damicornin) showed faint tissue autofluorescence but no spe­
cific labeling (Fig. 6, panels B Í  and B2s), demonstrating that the 
staining of the ectodermal granular cells was specific.
Damicornin Gene Expression following Bacterial Challenge— 
The regulation of damicornin gene expression on exposure to 
nonvirulent and virulent V. coralliilyticus was studied. Using 
q-RT-PCR, we analyzed the relative am ount of preprodami­
cornin transcripts in coral tissues 0, 3, 6, 9, 12, 15, and 18 days 
after bacterial challenge. There was no significant variation in 
transcript abundance after challenge with the nonvirulent bac­
teria (Fig. 7A), but large variation was evident after challenge
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FIGURE 7. Disturbance of preprodamicornin expression following infection by virulent bacteria. The transcrip tion  rate  of p rep rodam ico rn in  w as 
m easu red  by q-RT-PCR for sam ples a t DO, D3, D6, D9, D12, D15, and  D18 from  th e  nonviru len t {A) and  th e  v iru lent (ß) trea tm en ts . The relative expression  
w as norm alized using th e  geo m etric  m ean of th re e  refe rence  g en es  (norm alized relative quan tity , NRQ). The gray  and  black  h istog ram s rep re sen t th e  
relative expression  of th e  coral p rep rodam ico rn in  g en e  in th e  nonviru len t and  v iru lent tre a tm e n ts , respectively. The bars rep re sen t th e  m ean of 
replicates, and  th e  error bars rep re sen t th e  S.E. *, observ a tio n s th a t  d ev ia ted  significantly  (p <  0.05) from  o th ers  in th e  sam e tre a tm e n t (the nonviru len t 
and  th e  v iru lent trea tm en ts).
with the virulent V  coralliilyticus (Fig. 7B). Damicornin tran­
scripts markedly increased at day 6 (9.6-fold) and then declined 
significantly from day 12 to the end of the experiment (more 
than 44.5-fold at day 18 compared with day 0; Fig. IB). This 
strongly suggests that the coral pathogen V  coralliilyticus alters 
expression of the damicornin gene.
DISCUSSION
This report is the first concerning characterization, purifica­
tion, and expression of an AMP from a scleractinian coral. It is 
the most basal eumetazoan AMP characterized to date and the 
only antimicrobial agent identified in a scleractinian coral. The 
AMP (damicornin, from the coral P. damicornis) had antimi­
crobial activity against Gram-positive bacteria and the filamen­
tous fungus F. oxysporum but had little activity against Gram- 
negative bacteria including V  coralliilyticus, a specific 
pathogen of P. damicornis.
RACE-PCR experiments and MS-MS characterization of 
native damicornin showed that it is a 39-residue cationic AMP 
(theoretical pi = 9.64) containing 11 basic residues. Its meas­
ured molecular mass (m lz = 4492.740) indicates that dami­
cornin is folded by three intramolecular disulfide bridges 
involving the six cysteine residues in its sequence and that it has 
C-terminal amidation resulting from the removal of an end 
glycine residue. AMPs folded by three intramolecular disulfide 
bridges have been reported in many invertebrate and vertebrate 
species and often belong to the defensin superfamily (48). 
According to cysteine pairing, animal defensins are classified 
into four subfamilies, namely the vertebrate a-, ß-, and 0-de- 
fensins and the invertebrate defensins. The inclusion of dami­
cornin in these families appears inappropriate because of its 
specific cysteine array. This also applies to AMPs from other 
marine invertebrates (e.g. penaeidins) that contain three disul­
fide bridges and, like damicornin, have a cysteine array that 
differs from that of invertebrate defensins (49). Despite this dif­
ference, damicornin shares several features in common with 
invertebrate defensins: (i) it is particularly active against Gram-
positive bacteria and filamentous fungi but has limited activity 
against Gram-negative bacteria; (ii) it is characterized by a lack of 
hemolytic activity (48); and (iii) in terms of structural features, it 
can also have C-terminal amidation (50,51). The latter is common 
among cationic AMPs; it makes them more resistant to proteolysis 
and increases their net positive charge (49, 52-56).
From the complete ORF obtained in the present study, dami­
cornin is generated from a 107-residue precursor that we have 
term ed preprodamicornin. This includes in sequence a putative 
signal peptide (22 amino acids), an anionic proregion (45 amino 
acids), and a cationic damicornin sequence in the C-terminal 
position (40 amino acids). Thus, from the structure of its pre­
cursor, damicornin is probably generated sequentially as fol­
lows: (i) the signal peptide translocates preprodamicornin to 
the lumen of the rough endoplasmic reticulum and is cleaved 
off by a signal peptidase; (ii) the anionic proregion of predami- 
cornin is removed by proteolytic cleavage of the Arg-67-Ala-68 
bond by a processing enzyme that recognizes the dibasic motif 
(Arg-Arg) located ahead of the observed cleavage site; and (iii) 
the C-terminal extended glycine peptide substrate is hydroxylated 
by a peptidylglycine-a-hydroxylating mono-oxygenase, and the 
intermediate is cleaved by a peptidyl-a-hydroxyglycine-a-amidat- 
ing lyase, which leads to the formation of the mature a-amidated 
damicornin and the release of a glyoxylate. The first two steps of 
the process have been commonly reported in the maturation of 
AMP precursors (57-60). The mechanism occurring during the 
third step was described by Kolhekar et a í (61) and has been found 
in the processing of various AMPs (49, 50).
Damicornin shares several key features with invertebrate 
defensins: (i) it contains six cysteine residues involved in intra­
molecular disulfide bonds; (ii) it is mainly active against Gram- 
positive bacteria and filamentous fungi; (iii) it has no hemolytic 
activity; (iv) it has a classical precursor structure w ith a seg­
m ented organization containing a signal peptide followed by 
an anionic proregion and the cationic active peptide; (v) its 
precursor is processed by m echanism s found for other
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defensin precursors; and (vi) it has a C -term inal am idation 
typical of several invertebrate defensins and other AMPs of 
animal origin. However, dam icornin is m ore similar (cys­
teine array and sequence similarities) to aurelin from  the 
jellyfish A. aurita  (62). As w ith o ther invertebrate defensins 
having the same cysteine array (the so-called CS a ß  motif), 
including scorpion toxins (63, 64), dam icornin and aurelin 
have a com m on cysteine array w ith anem onia potassium  
channel toxins of type 1 (Fig. 1). A urelin has additional struc­
tural similarities w ith anem onia toxins; it has a Lys residue at 
position 28 followed by an essential hydrophobic residue, 
both of which have been shown to be crucial for toxin activ­
ity by blocking voltage-gated I<+ channels (62, 65-67). This 
essential dyad is no t present in dam icornin (Fig. 1). In addi­
tion, only dam icornin has C -term inal am idation. These data 
suggest that disulfide-containing AMPs (dam icornin and 
aurelin) and toxins from  cnidarians originated from  the 
same m olecular ancestor but have evolved independently to 
acquire specific molecular features and function.
The results show that damicornin is expressed by coral oral 
ectodermal cells and is located within intracellular granules. AMP 
expression in granular epithelial cells has been reported in both 
vertebrates (68-70) and invertebrates (71-73); this facilitates the 
apical release of AMP in mucus and thus its participation in muco­
sal defense and prevention of pathogen invasion. Our data suggest 
that the release of damicornin could be part of the coral epithelial 
defense. Whereas mature and active damicornin was isolated from 
corals challenged with nonvirulent bacteria, no antibacterial activ­
ity could be detected in unchallenged controls. However, dami­
cornin was expressed in both sets of animals, as evidenced by (i) 
similar transcription levels and (ii) similar immunostaining of 
ectodermal cell granules. This suggests that the inactive dami­
cornin precursor is stored in ectodermal cells and is activated by 
post-translational processing upon release when triggered by an 
immune challenge. Our Western blotting results support this 
hypothesis; a band of —10 kDa was detected by anti-damicornin 
antibody in unstressed coral extracts (supplemental Fig. S2). This 
band may correspond to prodamicornin, which has a theoretical 
molecular mass of 9.3 kDa. The hypothesis that active damicornin 
is matured and released in response to external signals is sup­
ported by previous studies showing the release of antibacterial 
molecules immediately after injury in P. damicornis and Stylo­
phora pistillata (23, 24).
A major finding of this study was that the expression of dami­
cornin was repressed in P. damicornis exposed to the virulent 
pathogen V  coralliilyticus. After a transient (10-fold) increase 
in damicornin transcript abundance during the first 6 days fol­
lowing infection, a dramatic decrease (50-fold) was observed 
from days 9 to 18. In contrast, no transcriptional change was 
observed when P. damicornis was exposed to the nonvirulent 
bacterial state. In a recent study of infection by V  coralliilyticus 
(27), we showed that the bacteria enter coral tissues 6 days after 
challenge. This suggests that the first phase of infection 
involves bacterial recognition by host cells, which triggers a 
nonspecific inflammatory response that activates damicornin 
gene transcription. In a second phase, following bacterial inva­
sion, the pathogen suppresses damicornin transcription. Simi­
lar mechanisms of immune suppression have been reported in
several intracellular bacteria including Shigella flexneri, which 
suppresses the transcription of several genes encoding AMPs 
following entry into intestinal cells (74). Although not reported 
to directly affect AMP expression, several marine Vibrio species 
have been shown to suppress or modulate host immune 
defenses (75-79).
In conclusion, this report is the first to characterize a scleractin­
ian AMP (damicornin). Damicornin has several features in com­
mon with invertebrate defensins and shares a specific cysteine 
array found in other cnidarian AMPs (aurelin from the jellyfish A. 
aurita) and toxins produced (anemonia). Structural similarities 
between AMPs and toxins have also been described for defensins 
and toxins of arthropods. This strongly suggests that AMPs and 
toxins have evolved from common molecular ancestors in diverse 
phyla. Damicornin was shown to be expressed and released from 
coral ectodermal cells in animals exposed to a nonpathogenic 
stimulus. Conversely, damicornin gene expression was repressed 
concomitantly with the entry of the coral pathogen V  coralliilyti­
cus into host ectodermal cells. This is the first evidence of AMP 
gene repression in a host -Vibrio interaction. Future studies will be 
necessary to assess whether this immune suppression accounts for 
the success of the coral pathogen.
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